179 research outputs found
Development and validation of a GC-MS method for the detection and quantification of clotiapine in blood and urine specimens and application to a postmortem case
INTRODUCTION:
Clotiapine is an atypical antipsychotic of the dibenzothiazepine class introduced in a few European countries since 1970, efficient in treatment-resistant schizophrenic patients. There is little published data on the therapeutic and toxic concentrations of this drug.
AIMS:
The aim of the present study is the development and validation of a method that allows the detection and quantification of clotiapine in blood and urine specimens by gas chromatography-mass spectrometry (GC-MS).
METHODS:
Validation was performed working on spiked postmortem blood and urine samples. Samples were extracted with liquid-liquid extraction (LLE) technique at pH 8.5 with n-hexane/dichloromethane (85/15 v/v) and analysis was followed by GC-MS. Methadone-d9 was used as internal standard.
RESULTS:
The limit of detection (LOD) was 1.2 and 1.3 ng/mL for urine and blood, respectively, while the lower limit of quantification (LLOQ) was 3.9 and 4.3 ng/mL, respectively. Linearity, precision, selectivity, accuracy, and recovery were also determined. The method was applied to a postmortem case. The blood and urine clotiapine concentrations were 1.32 and 0.49 μg/mL, respectively.
CONCLUSIONS:
A reliable GC-MS method for the detection and quantification of clotiapine in blood and urine samples has been developed and fully validated and then applied to a postmortem case
CRISPR-Cas and its wide-ranging applications: from human genome editing to environmental implications, technical limitations, hazards and bioethical issues
The CRISPR-Cas system is a powerful tool for in vivo editing the genome of most organisms, including man. During the years this technique has been applied in several fields, such as
agriculture for crop upgrade and breeding including the creation of allergy-free foods, for eradicating
pests, for the improvement of animal breeds, in the industry of bio-fuels and it can even be used as a
basis for a cell-based recording apparatus. Possible applications in human health include the making
of new medicines through the creation of genetically modified organisms, the treatment of viral
infections, the control of pathogens, applications in clinical diagnostics and the cure of human genetic
diseases, either caused by somatic (e.g., cancer) or inherited (mendelian disorders) mutations. One of
the most divisive, possible uses of this system is the modification of human embryos, for the purpose
of preventing or curing a human being before birth. However, the technology in this field is evolving
faster than regulations and several concerns are raised by its enormous yet controversial potential. In
this scenario, appropriate laws need to be issued and ethical guidelines must be developed, in order
to properly assess advantages as well as risks of this approach. In this review, we summarize the
potential of these genome editing techniques and their applications in human embryo treatment. We
will analyze CRISPR-Cas limitations and the possible genome damage caused in the treated embryo.
Finally, we will discuss how all this impacts the law, ethics and common sense
Sintesi e stereocontrollo di molecole organiche per lo sviluppo di metodologie innovative di interesse applicativo
Sintesi e stereocontrollo di molecole organiche per lo sviluppo di metodologie innovative di interesse applicativ
- …